ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,448Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 910

$1.17M Total Retail Price of All Prescriptions

Rank: 10 out of 910

908 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 908 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

17% of this provider’s 908 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 15,287 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
SIMVASTATIN 631 602 1 3
LEVOTHYROXINE SODIUM 624 567 2 1
LISINOPRIL 545 497 3 2
HYDROCODONE-ACETAMINOPHEN 418 366 S3 4 8
GABAPENTIN 324 312 5 13
AMLODIPINE BESYLATE 314 283 6 4
CIPROFLOXACIN HCL 302 271 7 48
METOPROLOL TARTRATE 280 253 8 7
FUROSEMIDE 271 242 9 9
LOSARTAN POTASSIUM 268 232 10 15
DONEPEZIL HCL 268 265 10 32
SPIRONOLACTONE 263 230 12 66
METFORMIN HCL 260 230 13 6
AZITHROMYCIN 257 235 14 41
OXYCODONE-ACETAMINOPHEN 249 187 S2 15 31
WARFARIN SODIUM 243 222 16 11
LOVASTATIN 231 225 17 20
OMEPRAZOLE 231 175 17 5
SERTRALINE HCL 216 158 19 24
ATORVASTATIN CALCIUM 204 182 20 14
RANITIDINE HCL 197 159 21 28
GLIMEPIRIDE 185 174 22 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 183 180 23 44
METOPROLOL SUCCINATE 176 151 24 21
HYDRALAZINE HCL 173 163 25 65
ZOLPIDEM TARTRATE 168 159 26 17
CLOPIDOGREL 164 151 27 35
LABETALOL HCL 164 162 27 212
PANTOPRAZOLE SODIUM 160 121 29 27
TRAZODONE HCL 154 128 30 37
CRESTOR 149 128 31 26
MIRTAZAPINE 145 138 32 68
LOSARTAN-HYDROCHLOROTHIAZIDE 138 126 33 79
CARVEDILOL 137 129 34 36
FLUTICASONE PROPIONATE 135 119 35 23
ATENOLOL 129 112 36 10
QUETIAPINE FUMARATE 129 102 36 70
HYDROCHLOROTHIAZIDE 121 111 38 12
NAMENDA 115 113 39 57
SPIRIVA 112 98 40 74
GLYBURIDE 109 100 R 41 46
POTASSIUM CHLORIDE 109 84 41 18
OXYCODONE HCL-ACETAMINOPHEN 109 34 S2 41 114
DIOVAN 100 98 44 34
JANTOVEN 98 98 45 254
TAMSULOSIN HCL 95 80 46 29
CYCLOBENZAPRINE HCL 95 71 R 46 80
TRIAMTERENE-HCTZ 92 85 48 39
PREDNISONE 91 77 49 43
TRAMADOL HCL 90 75 50 25
IBUPROFEN 90 62 50 75
OXYCODONE HCL 89 28 S2 52 42
TRIAMCINOLONE ACETONIDE 86 58 53 137
PLAVIX 86 82 53 53
ALLOPURINOL 78 76 55 33
MEGESTROL ACETATE 78 76 R 55 222
CELEBREX 77 75 57 85
CITALOPRAM HBR 76 56 58 19
ISOSORBIDE MONONITRATE ER 74 71 59 81
INSULIN SYRINGE 73 44 60 47
GLIPIZIDE 73 67 60 38
PREMARIN 73 62 R 60 127
PEN NEEDLE 73 61 60 124
NIFEDIPINE ER 72 67 64 107
BUSPIRONE HCL 69 67 65 226
VENLAFAXINE HCL ER 67 65 66 115
VESICARE 66 50 67 210
CYMBALTA 66 56 67 58
DIGOXIN 63 57 69 64
CLONIDINE HCL 63 61 69 51
AMITRIPTYLINE HCL 61 61 R 71 72
NEXIUM 60 23 72 93
OXYBUTYNIN CHLORIDE 57 49 73 83
PROAIR HFA 56 54 74 40
VERAPAMIL ER 55 51 75 99
OXYCONTIN 54 35 S2 76 126
DILTIAZEM ER 53 53 77 105
LIOTHYRONINE SODIUM 52 52 78 170
PROPRANOLOL HCL 51 49 79 120
VICTOZA 3-PAK 51 45 79 313
NIASPAN 51 47 79 140
AMOX TR-POTASSIUM CLAVULANATE 51 42 79 125
EXELON 50 50 83 181
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 18, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.